Inotiv(NOTV)

Search documents
Inotiv, Inc. Reschedules its Fiscal 2024 Second Quarter Results
Newsfilter· 2024-05-09 22:56
WEST LAFAYETTE, Ind., May 09, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the "Company"), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, today announced that the release of the Company's financial results for the three and six months ended March 31, 2024 and the conference call to discuss the results that were originally scheduled for Friday, May 10, 2024 are being res ...
Inotiv, Inc. to Report Fiscal 2024 Second Quarter Financial Results and Host Conference Call on Friday, May 10, 2024
Newsfilter· 2024-04-29 20:05
WEST LAFAYETTE, Ind., April 29, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the "Company", or "Inotiv"), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, today announced that it will issue its financial results for the fiscal 2024 second quarter ended March 31, 2024, on Friday, May 10, 2024, before the opening of the stock market. The Company will host a conference call ...
Inotiv(NOTV) - 2024 Q1 - Earnings Call Transcript
2024-02-07 23:54
Inotiv, Inc. (NASDAQ:NOTV) Q1 2024 Earnings Conference Call February 7, 2024 4:30 PM ET Company Participants Bob Yedid - Investor Relations Bob Leasure - President and CEO Beth Taylor - Chief Financial Officer Conference Call Participants Frank Takkinen - Lake Street Capital Markets Matt Hewitt - Craig-Hallum Operator Greetings. And welcome to the Inotiv’s First Quarter Fiscal Year 2024 Earnings Call. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow t ...
Inotiv(NOTV) - 2024 Q1 - Quarterly Report
2024-02-07 22:20
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the quarterly period ended December 31, 2023 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the transition period from ___________ to _____________. Commission File Number 000-23357 INOTIV, INC. (Exact name of the registrant as specified in its charter) IN ...
Inotiv(NOTV) - 2023 Q4 - Annual Report
2023-12-12 01:44
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the fiscal year ended September 30, 2023. OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the transition period from ___________ to _____________. Commission File Number 000-23357 INOTIV, INC. (Exact name of the registrant as specified in its charter) INDIANA ...
Inotiv(NOTV) - 2023 Q4 - Earnings Call Transcript
2023-12-12 00:45
Inotiv, Inc. (NASDAQ:NOTV) Q4 2023 Earnings Conference Call December 11, 2023 4:30 PM ET Company Participants Bob Yedid - LifeSci Advisors, Investor Relations Bob Leasure - Chief Executive Officer, President, and Director Beth Taylor - Senior Vice President of Finance and Chief Financial Officer Conference Call Participants Tim Daley - Wells Fargo Frank Takkinen - Lake Street Capital Markets Matt Hewitt - Craig-Hallum Dave Windley - Jefferies Operator Greetings, and welcome to the Inotiv's Fourth Quarter an ...
Inotiv(NOTV) - 2023 Q3 - Quarterly Report
2023-08-11 20:10
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the quarterly period ended June 30, 2023 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the transition period from ___________ to _____________. Commission File Number 000-23357 INOTIV, INC. (Exact name of the registrant as specified in its charter) INDIAN ...
Inotiv(NOTV) - 2023 Q3 - Earnings Call Transcript
2023-08-11 02:31
Inotiv, Inc. (NASDAQ:NOTV) Q3 2023 Earnings Conference Call August 10, 2023 4:30 PM ET Company Participants Bob Yedid - LifeSci Advisors, Investor Relations Bob Leasure - Chief Executive Officer, President, and Director Beth Taylor - Senior Vice President of Finance and Chief Financial Officer Conference Call Participants Tim Daley - Wells Fargo Matt Hewitt - Craig-Hallum Dave Windley - Jefferies Frank Takkinen - Lake Street Capital Markets Yuan Zhi - B. Riley Operator Good afternoon, ladies and gentlemen. ...
Inotiv(NOTV) - 2023 Q2 - Quarterly Report
2023-05-15 20:24
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the transition period from ___________ to _____________. Commission File Number 000-23357 INOTIV, INC. (Exact name of the registrant as specified in its charter) INDIA ...
Inotiv(NOTV) - 2023 Q2 - Earnings Call Transcript
2023-05-12 00:50
Inotiv, Inc. (NASDAQ:NOTV) Q2 2023 Earnings Conference Call May 11, 2023 4:30 PM ET Company Participants Devin Sullivan – Investor Relations-The Equity Group Bob Leasure – President and Chief Executive Officer Beth Taylor – Chief Financial Officer Conference Call Participants Matt Hewitt – Craig-Hallum Dave Windley – Jefferies Frank Takkinen – Lake Street Capital Markets Operator Good afternoon, and welcome to Inotiv’s Second Quarter Fiscal 2023 Financial Results Conference Call. At this time all participan ...